Skip to content
Home/Companies/Healthcare/Mimetas

Mimetas

Healthcare·Europe·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Mimetas?

Mimetas is a Healthcare company based in Europe, currently owned by Merieux Equity Partners since 2020.

Hand-verified · updated 2026-05-07

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Innovation 1 · 2014 · VC

Key facts

HQEurope
SectorHealthcare
StatusActive

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences
Broken String Biosciences
Active
BiotechUK· 2023
InnoSyn
InnoSyn
Active
PharmaNetherlands· 2023
LabQuality
LabQuality
Exited 2025
HealthcareFrance· 2023
to Aurevia
Cairdac
Cairdac
Active
MedTechFrance· 2022
Mablink Bioscience
Exited 2023
BiotechFrance· 2022
to Eli Lilly and Company
SeqOne Genomics
SeqOne Genomics
Active
BiotechFrance· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Mimetas?

Mimetas is currently owned by Merieux Equity Partners, through Mérieux Innovation 1, since 2020.

When did Merieux Equity Partners acquire Mimetas?

Merieux Equity Partners acquired Mimetas in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue